GLP-1 Impacts on Weight Management

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT07829016
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Disordered Eating Behaviors
  • Weight Management

Eligibility Criteria

Sex
ALL
Age
12 Years - 21 Years
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to learn about the long-term effects of GLP-1RAs (Ozempic, Wegovy, Rybelsus, Mounjaro, or Zepbound) in adolescents and young adults aged 12-21 who will start taking this drug for weight management. The main question it aims to answer is: How does starting GLP-1RAs impact eating behaviors and mental health symptoms? Participants starting to take GLP-1RAs as part of their medical care for weight management will answer online survey questions about their experience taking the drug for 1 year.

Key Dates

First listed
Sep 18, 2026
Start date
Sep 1, 2026
Status verified
Sep 2026
Primary completion
Sep 1, 2029
Completion
Sep 1, 2029

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Adolescents and Young Adults (12-21)
    Adolescents and Young Adults who plan to start GLP-1RA treatment for weight management.

Primary Outcome Measure

Change in the frequency of Objective Binge Episodes [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California San Francisco, Mission Bay CampusSan FranciscoCalifornia94158
Marissa Raymond-Flesch, MD/MPH
[email protected]
415-353-2747
Marissa Raymond-Flesch, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

By research site
University of California San Francisco, Mission Bay Campus· San Francisco, CA

Related Studies